TipRanks on MSN3d
Iterum Therapeutics Faces Commercialization Challenges for ORLYNVAH™ Despite FDA ApprovalIterum Therapeutics (ITRM) has disclosed a new risk, in the Sales & Marketing category. Iterum Therapeutics faces a significant business risk as ...
TipRanks on MSN6d
FuelPositive Faces Temporary Regulatory Challenge Amidst Progress in Green Ammonia CommercializationFuelPositive Corp. ( ($TSE:NHHH) ) just unveiled an update. FuelPositive Corporation announced it has missed the filing deadline for its annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback